Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear

Sponsor
University of Alcala (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05662722
Collaborator
(none)
60
1
3
12
5

Study Details

Study Description

Brief Summary

Headache is a very frequent symptom among the world population, the adult population with an active headache disorder are 46% for headache in general, 11% for migraine, 42% for tension-type headache and 3% for chronic daily headache. There are different therapeutic approaches for the improvement of headache. Transcutaneous stimulation of the auricular vagal nerve is being used for the treatment of headache due to the involvement of the vagus nerve in inflammation and pain modulation. On the other hand, galvanic current has shown a measurable effect by increasing parasympathetic activity. The objective of this clinical trial is to stimulate the auricular vagal nerve with galvanic current using a needle as an electrode that will be inserted into the concha of the ear. As a tool for measuring results, infrared thermography will be used to observe changes in facial skin temperature, since patients with high sympathetic activity present a characteristic pattern of "cold nose" and/or "cold patch". In addition, variables that record changes in autonomic activity such as skin conductance and heart rate variability will be collected.

Condition or Disease Intervention/Treatment Phase
  • Other: percutaneous needle electrolysis
  • Other: Dry needling
  • Other: Sham needling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
clinical random assignmentclinical random assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
triple (care provider, evaluator and outcome assessor)
Primary Purpose:
Treatment
Official Title:
Use of Infrared Thermography in the Measurement of Facial Blood Flow After the Application of Percutaneous Needle Electrolysis (PNE) on the Concha of the Ear
Anticipated Study Start Date :
Dec 26, 2022
Anticipated Primary Completion Date :
Apr 26, 2023
Anticipated Study Completion Date :
Dec 26, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pecutaneous electrolysis group

Subjects were treated twice (one day and one week). The technique consisted in the application of a galvanic electrical current using a needle as an electrode that will be inserted into the concha of the ear. The subjects were lying in supinus.

Other: percutaneous needle electrolysis
It´s an intervention of physiotherapy. It´s an invasive technique.

Other: dry needling group

Subjects were treated twice (one day and one week). The technique consisted in the puncture with a needle in the concha of the ear. The subjects were lying in supinus.

Other: Dry needling
It´s an intervention of physiotherapy. It´s an invasive technique.

Sham Comparator: Sham group

Subjects were treated twice (one day and one week). The technique consisted in the puncture with a sham-needle in the concha of the ear. The subjects were lying in supinus.

Other: Sham needling
It´s an intervention of physiotherapy. It´s an invasive technique simulation.

Outcome Measures

Primary Outcome Measures

  1. Skin temperature [Change from Baseline up to 30 minutes]

    It´s a camera to take infrared thermal images. The images provide facial temperature measurement.

  2. Headache Impact Test (HIT-6) [Change from Baseline up to 30 minutes]

    Headache Impact (HIT) is a tool used to measure the impact headaches have on your ability to function at work, home, school and in social situations. Your score shows you the effect that headaches they have in normal daily life and in their ability to function.A score of 60 or higher is associated with a very severe impact. A score equal to or less than 49 is associated with a low impact.

Secondary Outcome Measures

  1. Skin bioimpedance [Change from Baseline up to 30 minutes]

    It´s a system to acquire bio-electrical and physiological signals (galvanic skin conductance, heart rate variability), and transfer these signals to a computer for processing an analysis.

  2. Heart rate variability [Change from Baseline up to 30 minutes]

    It´s a system to acquire bio-electrical and physiological signals (galvanic skin conductance, heart rate variability), and transfer these signals to a computer for processing an analysis.

  3. Numerical Rating Scale [Change from Baseline up to three months]

    Patients vebally requested to rate their pain: "Rate your pain from = (no pain) to 10 (unbearable pain)

  4. Patients global impressions scale: [Change from Baseline up to three months]

    It´s the Patient reported outcomes counterpart to the Clinical Global Impressions scale. The PGIS are 1-item questionnaire that ask an individual patient to rate the severity of a specific condition (single-state scales) at baseline and or to rate at endpoint the perceived change in is/her condition in response to therapy; in the other hand PGIC measures change in clinical status.

  5. Pittsburg Sleep Quality Index score [Change from Baseline up to three months]

    Improvement in Pittsburg Sleep Quality Index (PSQI), Scale is 0 to 21, higher score is worse outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Headache with a frequency of at least one monthly episode.

  • Present the "cold nose" and/or "cold patch" pattern

Exclusion Criteria:
  • Do not present a "cold nose" and/or "cold patch" pattern

  • Pregnant women

  • Subjects with facial alterations that may affect facial vascularization (sinusitis, allergies...)

  • Patients with belonephobia or allergy to metals or any material used in the procedure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Physioterapy and Pain center research Alcalá de Henares Madrid Spain 28805

Sponsors and Collaborators

  • University of Alcala

Investigators

  • Principal Investigator: Daniel Pecos-Martin, PhD, Alcala University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Dr. Daniel Pecos Martín, Principal Investigator, University of Alcala
ClinicalTrials.gov Identifier:
NCT05662722
Other Study ID Numbers:
  • CEID/2022/2/028
First Posted:
Dec 22, 2022
Last Update Posted:
Dec 22, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 22, 2022